A Virtual Glucose Homeostasis Model for Verification, Simulation and Clinical Trials
|
|
- Wilfred Hamilton
- 5 years ago
- Views:
Transcription
1 A Virtual Glucose Homeostasis Model for Verification, Simulation and Clinical Trials Neeraj Kumar Singh INPT-ENSEEIHT/IRIT University of Toulouse, France September 14, 2016 Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
2 Outline 1 Critical Systems 2 Context and Problems 3 Glucose Homeostasis Models 4 Formalization of GH 5 GH Simulator Framework 6 Hardware Implementation of GH 7 Conclusion & Future Work Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
3 Critical Systems Definition A system whose failure may result in injury, loss of life, economical loss or serious environmental damage. These systems require interaction between computational and physical elements. Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
4 System Failures System Failures Therac-25 ( ): six people overexposed to radiation. Pacemaker and ICD ( ): 17,323 pacemakers and ICDs were explanted that includes 61 deaths. Insulin Infusion Pump (IIP) (2010): 5000 adverse events that includes 30 deaths. Missing Malaysian Plane MH370 (8 March, 2014): Unknown. Satellite Failure:+150: Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
5 Context and Problems Context Development of virtual model for verification, simulation and clinical trials that can be used in the development process of medical devices. Current Challenges Increasing complexity of the critical medical systems. Lack of biological simulation/environment for medical devices. Better techniques for requirement analysis. Needs some sound techniques to meet regulators, and certification standards. Modelling critical medical systems using human-in-loop architecture. Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
6 Insulin Infusion Pump Insulin Infusion Pump An insulin pump is a small, complex, software-intensive medical device that allows controllable, continuous subcutaneous infusion of insulin to patients. Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
7 IIP Requirements REQ1: The device must undergo a power-on-self-test (POST) whenever device power is turned on. REQ2: The device must suspend all active basal delivery or bolus deliver during pump refilling and in the case of system failure. REQ3: The device shall allow the user to manage system functionalities related to: stopping insulin delivery; validating basal profiles parameters; reminder management; and validating bolus preset parameters. REQ4: The device shall allow the user to define a basal profile that consists of an ordered set of basal rates, ordered over a 24 hour day, as well as a temporary basal, that consists of a basal rate for a specified duration of time within a 24 hour day. REQ5: The device can contain several basal profiles, but only one basal profile can be active at any single point in time. REQ6: The device must allow the user to override an active basal profile with a temporary basal, without changing the existing basal profile. REQ7: The device shall resume the active basal profile after the temporary basal terminates. Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
8 IIP Requirements REQ8: The device shall enforce a maximum dosage for the normal bolus or extended bolus. REQ9: The user shall be able to stop the active normal or extended bolus. REQ10: The device must maintain an electronic log of every operation associated with an user alert, such as an audio alarm. REQ11: The device shall maintain a history of basal and bolus dosages over the past n days. n always differs among brands, though most store up to 90 days of data. REQ12: The device shall enable the user to create a food database that can be used to store food or meal descriptions and the carbs associated with them. REQ13: The device shall allow to the user to change parameter settings of basal profile, bolus preset, and temporary basal. REQ14: The device shall provide feedback to the user regarding system and delivery status. Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
9 Objectives To identify gaps or inconsistencies in the IIP requirements. Developing a closed-loop model for verification and validation of IIP. Analysing system interaction between the GH model and IIP. Developing a simulation model from the formal virtual GH model. Developing a test bench using the virtual GH model and simulation for clinical trials of IIPs. Generating test cases to test the functional correctness of IIP software. Developing patient specific model at various level of system development. The virtual environment model can be used by medical industries during the product development. The virtual GH environment model can be used by regulators for validating and certifying the medical devices. Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
10 Glucose Homeostasis Models Clinical Models Models for diagnostic tests control progression complications Non-Clinical Models Models for insulin-glucose, hepatic glucose, glucagon, and insulin receptor dynamics beta-cell insulin release brain glucose homeostasis Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
11 Glucose Homeostasis Models Use of the Models To present a simulation of the glucose homeostasis system to understand the actual behavior. To assist the medical experts for simulation purpose of the glucose dynamics. Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
12 Glucose Homeostasis Models Use of the Models To present a simulation of the glucose homeostasis system to understand the actual behavior. To assist the medical experts for simulation purpose of the glucose dynamics. Disadvantages Existing models are based on complex mathematics, therefore these models are difficult and make simulation very time-consuming. are not suitable for presenting an abstract behavior of GH. are not suitable for verification purpose. Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
13 Glucose Homeostasis System HighCPlasmaC GlucoseCLevel NormalCGlucoseC LevelCMaintainedC LowCPlasmaC GlucoseCLevel GlucoseC LevelCDrops GlucoseC LevelCRises GlucoseCUtilizationC andcstoragecincliverc ascglycogen β-cells Pancreas α-cells LiverCConvertsC GlycogenCtoC Glucose Insulin Release Glucagon Release Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
14 Glucose Homeostasis Automata Glucose Level Drops Hi No Lo Glucose Level Rises St Bc Ac Tr Insulin Release Glucagon Release Li Figure: The Glucose Homeostasis Automata Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
15 The Glucose Homeostasis Definition Definition 1 (The Glucose Homeostasis System) Given a set of nodes N, a transition T is a pair (i, j), with i, j N. A transition is denoted by i j. The glucose homeostasis system is a tuple GHS = (N, T, N 0 ) where: N = { Hi, No, Lo, Ac, Bc, Li, St, Tr } is a finite set of landmark nodes in the glucose homeostasis network; T N N = {No Hi, Hi No, No Lo, Lo No, Hi Hi, No No, Lo Lo, Hi Bc, Lo Ac, Bc Li, Ac Li, Li St, Li Tr, St No, Tr No, St Hi, Tr Lo, Tr Hi} is a set of transitions to present data flow between two landmark nodes; N 0 = No is the initial landmark node (normal glucose level); Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
16 Abnormal Glucose Homeostasis System Hyperglyoemia-induced DiabetesbComplications HighbPlasmab GlucosebLevel NormalbGlucoseb LevelbMaintainedb LowbPlasmab GlucosebLevel Persistent HighbPlasmab GlucosebLevel Persistent LowbPlasmab GlucosebLevel Persistent HighbPlasmab GlucosebLevel InsulinbResistance inbcellsb Beta-CellsbDefect; Insufficientborbno InsulinbSecretion β-cells Pancreas α-cells Insufficientborb nobglucagonb Secretion ExcessbInsulinb orbextreamb Exercise Excessb Glucagonb Secretion Insulin Release Alpha-CellsbDefect; Abnormalb GlucagonbRelease Figure: Abnormal Glucose Homeostasis System Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
17 Blood Glucose Level Property 1 (Blood Glucose Level) The blood glucose level defines different stages, such as hyper- glycemia, hypoglycemia and normal. The glucose level is low (hypoglycemia) if FPG [0,70) or OGTT [0,70), and the glucose level is high (hyperglycemia) if FPG 125 or OGTT 200, and the glucose level is normal if FPG [70,100) or OGTT [70,140). We classify pre-diabetes to be the range where FPG [100,125) or OGTT [140,200). Blood Sugar Level Fasting Plasma Glucose (FPG) Oral Glucose Tolerance Test (mg/dl) (mg/dl) Normal Pre-Diabetes High glucose 126 or above 200 or above Low glucose Table: FPG and OGTT Test Values for Glucose Level Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
18 Abstract Model Context axm1 : Glucose level, {Normal}, {High}, {Low}) axm2 : partition(ghs, {OK}, {KO}) Hi No Lo Figure: Automata of an Abstract Model Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
19 Abstract Machine inv1 : Current Glucose Level Glucose level inv2 : Diabetic Condition GHS inv3 : Diabetic Condition = KO Current Glucose Level = High Current Glucose Level = Low inv4 : Current Glucose Level = Normal Diabetic Condition = OK EVENT Normal Glucose WHEN grd1 : Current Glucose Level = Normal Current Glucose Level = Low Current Glucose Level = High THEN act1 : Current Glucose Level := Normal act2 : Diabetic Condition := OK END Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
20 Abstract Machine EVENT High Glucose WHEN grd1 : Current Glucose Level = Normal Current Glucose Level = High THEN act1 : Current Glucose Level := High act2 : Diabetic Condition := KO END EVENT Low Glucose WHEN grd1 : Current Glucose Level = Normal Current Glucose Level = Low THEN act1 : Current Glucose Level := Low act2 : Diabetic Condition := KO END N. K. Singh, Hao Wang, Mark Lawford, Thomas S. E. Maibaum, and Alan Wassyng Formalizing the Glucose Homeostasis Mechanism, 16th International Conference on Human-Computer Interaction (HCI 2014), LNCS, Springer International Publishing, pp , Vol-8529, Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
21 Progressive Refinements Refinement Gradually introduce details and complexity to the specification by removing non-determinism and by adding more events. Refinement 1 : To introduce the α-cells and β-cells of Pancreas including their releasing functions and defects. Refinement 2 : To define the liver behaviour for converting or storing the glucose in the body. Refinement 3 : To add the abnormal conditions of Pancreas, diabetic conditions, and diabetes complications. Refinement 4 : To introduce the Blood Sugar Concentration for assessing the Diabetes and Pre-diabetes. Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
22 GH Simulator Framework Modeling Tools and Computation Tools Finite elements, Finite differences, Lumped elements, etc. Physiology of GH Physiology of the Pancreas Formal Specification of GH Physiology of the Liver Insulin-glucose Dynamics Glucagon-glucose Dynamics Simulation Kernel User Interface and Visualization of GH GH Abnormality Physiology of pancreatic alpha-cells and beta-cell Required Parameters Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
23 Hardware Implementation of GH Hardware Platform FPGA, Arduino, Snickerdoodle, etc Formal Specification of GH GH Simulation Modeling and Implementation of GH Model Matlab or LabVIEW User Interface and Visualization of GH Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
24 Usage Scenarios of Environment Model Behavioural Requirements To Discover Essential Safety Properties Patient Safety in Closed-loop To Generate Automatic Test Cases Test Bench for Clinical Trials of IIPs Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
25 Conclusion & Future Work Conclusion Logic based mathematical modelling of the GH (Normal and Abnormal) Developed a stepwise formal model of GH environment model Applying model checking and theorem prover to prove safety properties. Proposed Simulation framework Proposed Hardware Implementation framework To meet the V&V requirements of certification standards like FDA etc. Future Work Integration of GH model and IIP for developing the closed-loop model Development of GH simulator Test bench for IIPs through developing the hardware platform of GH Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
26 Neeraj Kumar Singh A Perspective on Environment Modelling September 14, / 25
Stepwise Formal Modelling and Reasoning of Insulin Infusion Pump Requirements
Stepwise Formal Modelling and Reasoning of Insulin Infusion Pump Requirements Neeraj Kumar Singh 1(B), Hao Wang 2, Mark Lawford 1, Thomas S.E. Maibaum 1, and Alan Wassyng 1 1 McMaster Centre for Software
More informationGROUP PROJECT REQUIREMENTS AND SPECIFICATION
GROUP PROJECT REQUIREMENTS AND SPECIFICATION I PROJECT BACKGROUND People with diabetes cannot make their own insulin, a hormone that is normally secreted by the pancreas. Insulin is essential to metabolize
More informationRELEASED. first steps. Icon Icon name What it means
Icon Icon name What it means Connection The connection icon appears green when the Sensor feature is on and your transmitter is successfully communicating with your pump. The connection icon appears gray
More informationCareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes
CareLink Management Software for Diabetes software REPORT REFERENCE GUIDE How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used
More informationReport Reference Guide
Report Reference Guide How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used to generate the sample reports was from sample patient
More informationAmbulatory Artificial Pancreas Platform (AAPP) User Manual
Ambulatory Artificial Pancreas Platform (AAPP) User Manual Welcome to the Artificial Pancreas User Manual. This manual is intended to teach you how to use the system in your clinical trial. If questions
More information1. Continuous Glucose Monitoring
1. Continuous Glucose Monitoring 1. Physiology of interstitial fluid glucose 2. Comparison of CGM and self-monitored blood glucose (SMBG) data 3. Insulin dosing indication in BGM vs. CGM & the FDA 4. Protection
More informationReport Reference Guide. THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1
Report Reference Guide THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1 How to use this guide Each type of CareLink report and its components are described in the following sections.
More informationThe Realities of Technology in Type 1 Diabetes
The Realities of Technology in Type 1 Diabetes May 6, 2017 Rosanna Fiallo-scharer, MD Margaret Frederick, RN Disclosures I have no conflicts of interest to disclose I will discuss some unapproved treatments
More informationControl of Glucose Metabolism
Glucose Metabolism Control of Glucose Metabolism The pancreas is both an exocrine and endocrine gland. It secretes digestive enzymes into the duodenum (exocrine) and 3 specific hormones into the bloodstream
More informationTHERAPY MANAGEMENT SOFTWARE FOR DIABETES
THERAPY MANAGEMENT SOFTWARE FOR DIABETES Report Report Interpretation Reference Guide Guide 2009 Medtronic MiniMed. All rights reserved. 6025274-012_a CareLink Pro Report Reference Guide 0 p.2 Adherence
More informationDiabetes Medical Management Plan (DMMP) Handout C.1
This plan should be completed by the child s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant program staff and copies should be kept in a place that
More informationRELEASED. Clearing your active insulin
To clear all your settings: 1. Make sure the pump is not connected to your body. 2. Go to the Manage Settings screen. Menu > Utilities > Manage Settings 3. Simultaneously press and hold and until the Manage
More informationWelcome to CareLink Pro
Reference Guide Welcome to CareLink Pro This guide was developed to serve as a reference for obtaining patient data and reviewing CareLink Pro reports. Getting Started with CareLink Pro Adding New Patients
More informationAuthorization for MAT Diabetes Certified Staff to Administer Insulin and/or Glucagon
Medication Administration Training for Child Day Programs Handout B.1 Authorization for MAT Diabetes Certified Staff to Administer Insulin and/or Glucagon Child s Name: Child s Date of Birth: Child Day
More informationTHERAPY MANAGEMENT SOFTWARE FOR DIABETES
THERAPY MANAGEMENT SOFTWARE FOR DIABETES Report Report Interpretation Reference Guide Guide 2007 Medtronic MiniMed. All rights reserved. 6025274-0U2 120707 CareLink Pro Report Reference Guide 0 p.2 Sensor
More informationArtificial Pancreas Device Systems. Populations Interventions Comparators Outcomes. pump. pump
Protocol Artificial Pancreas Device Systems (10130) Medical Benefit Effective Date: 04/01/18 Next Review Date: 01/19 Preauthorization Yes Review Dates: 03/15, 03/16, 03/17, 01/18 Preauthorization is required.
More informationToward Plug and Play Medical Cyber-Physical Systems (Part 2)
Toward Plug and Play Medical Cyber-Physical Systems (Part 2) Insup Lee PRECISE Center School of Engineering and Applied Science University of Pennsylvania EMSIG Autumn School Copenhagen, Denmark November
More informationDiabetes Medical Management Plan (DMMP) Adapted from Helping the Student with Diabetes Succeed: A Guide for School Personnel (2016)
Diabetes Medical Management Plan (DMMP) Adapted from Helping the Student with Diabetes Succeed: A Guide for School Personnel (2016) This plan should be completed by the student's personal diabetes health
More informationAdvances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier?
Advances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier? Alan B Schorr DO FAAIM FACE www.sugardoc.com abs@sugardoc.com Disclosures
More informationPredicts and helps prevent lows with. zero fingersticks NOW FEATURING BASAL-IQ TECHNOLOGY
Predicts and helps prevent lows with * zero fingersticks NOW FEATURING BASAL-IQ TECHNOLOGY Basal-IQ Technology is not a substitute for active self-management of your diabetes. Please see back cover for
More informationArtificial Pancreas Device Systems. Populations Interventions Comparators Outcomes Individuals: With type 1 diabetes
Protocol Artificial Pancreas Device Systems Medical Benefit Effective Date: 07/01/18 Next Review Date: 01/20 Preauthorization Yes Review Dates: 03/15, 03/16, 03/17, 01/18, 05/18, 01/19 Preauthorization
More informationFigure 2.1: Glucose meter
CHAPTER TWO: MONITORING TECHNOLOGIES 2.1 Introduction Glucose monitoring is a method of self-testing glucose (blood sugar) levels for the management of diabetes. Traditionally, it involves pricking the
More informationThe Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes
The Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes Sarah Dombrowski, PharmD, BCACP Pennsylvania Pharmacists Association 10/20/18 1 Objectives At the completion of this activity,
More information9-A. Diabetes Medical Management Plan
of Plan: Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed with relevant school staff and copies should
More informationInsulin Pumps Available in Canada
Insulin Pumps Available in Canada A Comparison from WaltzingTheDragon.ca *Accu-Chek Animas Ping/Vibe Medtronic Minimed 630G Omnipod ABOUT FORM: Is the insulin pump Tubing- Free? Is the pump? Or Water-Resistant?
More informationInsulin Pump Therapy in children. Prof. Abdulmoein Al-Agha, FRCPCH(UK)
Insulin Pump Therapy in children Prof. Abdulmoein Al-Agha, FRCPCH(UK) aagha@kau.edu.sa Highlights Evolution of insulin pump Pumps mimics Pancreas Goals of diabetes care What lowers HbA1c Criteria for selection
More informationNEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP
NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP No commercial support or sponsorship was received for this project I have nothing to disclose OBJECTIVES Identify at
More informationWarren Township School District Diabetes IHCP
Warren Township School District Diabetes IHCP of Plan: Diabetes Health Management Plan This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed
More informationDISCOVER THE POWER OF CONNECTION MINIMED 640G
DISCOVER THE POWER OF CONNECTION MINIMED 640G INSULIN PUMP THERAPY CHANGING LIVES TODAY Have you just been diagnosed with insulin dependent diabetes? Perhaps you ve been on multiple daily injection therapy
More informationGetting Started. Learning Guide. with Insulin Pump Therapy. PUMP Foundations. for the MiniMed 530G with Enlite
Getting Started with Insulin Pump Therapy for the MiniMed 530G with Enlite Learning Guide PUMP Foundations MiniMed 530G Insulin Pump Settings Form: We recommend that you record all settings on this form
More informationDiabetes Management: Current High Tech Innovations
Diabetes Management: Current High Tech Innovations How Far We ve Come in the Last 40 Years William V. Tamborlane, MD Department of Pediatrics Yale School of Medicine Disclosures I am a consultant for:
More informationDiabetes Medical Management Plan
Diabetes Medical Management Plan This plan should be completed by the student's personal health care team and parents/guardian. It should be reviewed with relevant school staff and copies should be kept
More informationGlucose Concentration Simulation for Closed-Loop Treatment in Type 1 Diabetes
American Society for Engineering Education (ASEE), Northeast Section Annual Conference, April 27-28, 208 Glucose Concentration Simulation for Closed-Loop Treatment in Type Diabetes Marilyn Urrea, Nora
More informationRancocas Valley Regional High School Diabetes Medical Management Plan
of Plan: Rancocas Valley Regional High School Diabetes Medical Management Plan Individualized Healthcare Plan/ 504 Plan will be completed by the school nurse in consultation with the student s parent /guardian
More informationLive life, less complicated. InPen MOBILE APP. Healthcare Provider INSTRUCTIONS FOR USE. CompanionMedical.com
InPen MOBILE APP Healthcare Provider INSTRUCTIONS FOR USE TABLE OF CONTENTS Introduction...3 InPen Mobile App...3 Intended Use...3 Indications for Use...3 Contraindications...3 Start Orders...4 General
More informationTechnology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE
Technology for Diabetes: 101 Basic Rules of the Road Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Quick Pump Facts! o Constant insulin supply o Pager-sized mini-computer worn
More informationFormalizing Electrocardiogram (ECG) Signal Behavior in Event-B
Formalizing Electrocardiogram (ECG) Signal Behavior in Event-B Hussam Al-Hamadi and Amjad Gawanmeh and Mahmoud Al-Qutayri Department of Electrical and Computer Engineering Khalifa University, UAE Email:{Hussam.alhamadi,
More informationGlycemic Control IU Health Diabetes Centers
Glycemic Control IU Health Diabetes Centers Central Nursing Orientation 3/10/2014 1 Objectives Identify laboratory results that diagnosis diabetes and reflect glycemic control Describe glycemic control
More informationMONMOUTH COUNTY VOCATIONAL SCHOOLS
Diabetes Medical Management Plan/Individualized Healthcare Plan Part A: Contact Information must be completed by the parent/guardian. Part B: Diabetes Medical Management Plan (DMMP) must be completed by
More informationContour Diabetes app User Guide
Contour Diabetes app User Guide Contents iii Contents Chapter 1: Introduction...5 About the CONTOUR DIABETES app...6 System and Device Requirements...6 Intended Use...6 Chapter 2: Getting Started...7
More informationCaregiver Guide WITH THE OMNIPOD. MyOmniPod.com RYAN OMNIPOD WEARER
RYAN OMNIPOD WEARER Insulet Corporation 9 Oak Park Drive Bedford, MA 01730 USA 800 591 3455 / 781 457 5098 WITH THE OMNIPOD MyOmniPod.com 15569-AW R1 12/12 2 Caregiver Guide 3 Get to know the OmiPod. >
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardians. It should be reviewed with relevant school staff
More informationLander County School District
Lander County School District of Plan: Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed with relevant
More informationDiabetes Medical Management Plan
of Plan: School year: Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed with relevant school staff and
More informationBLOOD GLUCOSE METER TEST STRIP STEP THERAPY CRITERIA
BLOOD GLUCOSE METER TEST STRIP STEP THERAPY CRITERIA Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan.
More informationUNDERSTANDING THE BASIC FEATURES AND MANAGEMENT IN THE SCHOOL SETTING CHRISTINE HERTLER RN BSN CDE & MARY MCCARTHY RN CDE
UNDERSTANDING THE BASIC FEATURES AND MANAGEMENT IN THE SCHOOL SETTING CHRISTINE HERTLER RN BSN CDE & MARY MCCARTHY RN CDE The insulin pump Replaces injections Delivers insulin through a soft cannula
More informationDiabetes Medical Management Plan
MADISON CONSOLIDATED SCHOOLS Diabetes Medical Management Plan Date of Plan: Effective Dates : The student s personal health care team and parents/guardian should complete this plan. It should be reviewed
More informationFREEHOLD REGIONAL HIGH SCHOOL DISTRICT. Parents/Guardian of
FREEHOLD REGIONAL HIGH SCHOOL DISTRICT Parents/Guardian of In order to comply with N.J.S.A. 18A:40-12.11-21, which addresses the care of the diabetic student in the school setting, the attached packet
More informationControl of Blood Sugar Levels
Why? Control of Sugar Levels What hormones are involved in the homeostasis of blood sugar? All living things use as a source of energy. In vertebrates it is critical that the levels of in the blood are
More informationDISCOVER THE POWER OF CONNECTION MINIMED 640G
DISCOVER THE POWER OF CONNECTION MINIMED 640G INSULIN PUMP THERAPY CHANGING LIVES TODAY Has your child just been diagnosed with insulin dependent diabetes? Or perhaps they ve been on multiple daily injection
More informationDiabetes Medical Management Plan/Individualized Healthcare Plan. Part A: Contact Information must be completed by the parent/guardian.
Middle School 908 689 0750 ext. 2020 WARREN HILLS REGIONAL SCHOOL DISTRICT Washington, NJ 07882 HEALTH OFFICES High School 908 689 3050 ext. 2 MS FAX 908 835 0570 HS FAX 908 835 8511 Diabetes Medical Management
More informationWhat is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?
What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? Dr. Fiona Wotherspoon Consultant in Diabetes and Endocrinology Dorset County Hospital Fiona.Wotherspoon@dchft.nhs.uk
More informationProceedings of the 5th WSEAS International Conference on Telecommunications and Informatics, Istanbul, Turkey, May 27-29, 2006 (pp )
A Predictive Control Approach For Nonlinear Systems MALIK F. ALAMAIREH, MOHAMMAD R. HASSAN Department of Computer Science Amman University Assalt 19112 P. O. Box 5043 JORDAN Abstract: - The theory of artificial
More informationGlucagon Administration. Molalla River School District
Glucagon Administration Molalla River School District Laws that have were created to allow for administration of epinephrine in the school based setting were revised to include glucagon administration
More informationINTERNATIONAL JOURNAL OF PURE AND APPLIED RESEARCH IN ENGINEERING AND TECHNOLOGY
INTERNATIONAL JOURNAL OF PURE AND APPLIED RESEARCH IN ENGINEERING AND TECHNOLOGY A PATH FOR HORIZING YOUR INNOVATIVE WORK A SLIDING MODE CONTROL ALGORITHM FOR ARTIFICIAL PANCREAS NIRLIPTA RANJAN MOHANTY
More information[Insert School Logo] School Grade Teacher Physician Phone Fax Diabetes Educator Phone 504 Plan on file Yes No
[Insert School Logo] 1 INDIVIDUALIZED HEALTH PLAN (IHP for SCHOOLS): DIABETES WITH PUMP Picture of Student Student DOB Home Phone Mother Work Phone Cell Phone Father Work Phone Cell Phone Guardian School
More informationDIABETES MANAGEMENT PLAN 2017
EARLY CHILDHOOD EDUCATION AND CARE SETTING Insulin pump therapy Use in conjunction with Action Plan DIABETES MANAGEMENT PLAN 2017 Name of child: Name of centre: of birth: Age: This plan should be reviewed
More informationDiabetes Medical Management Plan
of Plan: Diabetes Medical Management Plan These orders remain in effect during the school day, school sponsored activities, and school sponsored overnight trips. This plan should be completed by the student
More informationUSING THE MINIMED 670G SYSTEM. Instructions for the Experienced MiniMed 630G System User
USING THE MINIMED 670G SYSTEM Instructions for the Experienced MiniMed 630G System User This is a supplemental guide. For complete instructions and safety information, please see your MiniMed 670G System
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant school staff
More informationInsulin Pump Therapy. WakeMed Children s Endocrinology & Diabetes WakeMed Health & Hospitals Version 1.3, rev 5/21/13 MP
Insulin Pump Therapy WakeMed Children s Endocrinology & Diabetes Overview What is an insulin pump? What are the advantages and disadvantages of an insulin pump? Lifestyle Changes Food Management Exercise
More informationDiabetes Medical Management Plan
Date of Plan: Diabetes Medical Management Plan Effective Dates: This plan should be completed by the student's personal health care team and parents/guardian. It should be reviewed with relevant school
More informationSFHDiabPT03 Provide dietary education for an individual with Type 1 diabetes who is contemplating insulin pump therapy
Provide dietary education for an individual with Type 1 diabetes who is contemplating insulin pump therapy Overview This standard concerns the activities of helping an individual with diabetes understand
More informationDate of birth: Type 2 Other: Parent/guardian 1: Address: Telephone: Home: Work: Cell: address: Camper physician / health care provider:
Day & Evening Camp 2018 Specialized Health Care Diabetes Medical Management Plan Must be completed if your camper has diabetes. Parent/guardian and physician signature required. **We will also accept copies
More informationDate of Diabetes diagnosis Type I Type II. School Nurse Phone. Mother/Guardian. Address. Home phone Work Cell. Father/Guardian.
Diabetes Medical Management Plan/Individualized Healthcare Plan This plan should be completed by the student s physician, personal diabetes healthcare team and parent/guardians. It should be reviewed with
More informationDiabetes Medical Management Plan
SCHOOL DISTRICT OF LEE COUNTY HEALTH SERVICES Print Form Date of Plan Diabetes Medical Management Plan This plan should be completed by the student's personal health care team and parents/guardian. It
More informationOutline Insulin-Glucose Dynamics a la Deterministic models Biomath Summer School and Workshop 2008 Denmark
Outline Insulin-Glucose Dynamics a la Deterministic models Biomath Summer School and Workshop 2008 Denmark Seema Nanda Tata Institute of Fundamental Research Centre for Applicable Mathematics, Bangalore,
More informationVIRTUAL PATIENTS DERIVED FROM THE
VIRTUAL PATIENTS DERIVED FROM THE CARELINK DATABASE Benyamin Grosman PhD Senior Principle Scientist Medtronic Diabetes WHY VIRTUAL PATIENT MODELING? Reduce the cost of clinical trials Use models in conjunction
More informationThe In-Clinic Close Loop Experience in the US
The In-Clinic Close Loop Experience in the US Keystone Symposium, Practical Ways to Achieve Targets in Diabetes Care July 14, 2012 Francine Ratner Kaufman, MD Chief Medical Officer, VP Global Medical,
More informationArtificial Pancreas Device System (APDS)
Medical Policy Manual Durable Medical Equipment, Policy No. 77 Artificial Pancreas Device System (APDS) Next Review: October 2019 Last Review: October 2018 Effective: November 1, 2018 IMPORTANT REMINDER
More informationBROWNSBURG COMMUNITY SCHOOL CORPORATION
BROWNSBURG COMMUNITY SCHOOL CORPORATION HEALTH SERVICES 111 Eastern Avenue Brownsburg, IN 46112 (317) 852-1046 Fax (317) 852-1048 www.brownsburg.k12.in.us DIABETES MANAGEMENT PLAN for DOB School Name Year
More informationFor patients uncontrolled on multiple daily injections of insulin. A quick-start guide for your practice ALL-DAY CONTROL WITH
For patients uncontrolled on multiple daily injections of insulin A quick-start guide for your practice Dosing guidance 1,* V-Go: 3 options 1 For initiating V-Go in patients switching from MDI The majority
More informationTO BE COMPLETED BY LICENSED HEALTH CARE PROFESSIONAL
PART I OFFICE OF CATHOLIC SCHOOLS DIOCESE OF ARLINGTON DIABETES MEDICAL MANAGEMENT PLAN Page 1 of 5 TO BE COMPLETED BY PARENT OR GUARDIAN Student School Date of Birth Date of Diagnosis Grade/ Teacher Physical
More informationPump Basics for the School Nurse. Children's Endocrinology Center of Dallas
Pump Basics for the School Nurse Children's Endocrinology Center of Dallas Pump Basics Covers: A general overview of the insulin pump Refer to the manufacturer s website for the specific features of each
More informationSCHOOL HEALTH PLAN: DIABETES
BRANDON FLORENCE MCLAURIN NORTHWEST PELAHATCHIE RANKIN COUNTY SCHOOL DISTRICT GREAT TO BEST PISGAH PUCKETT RICHLAND RANKIN COUNTY SCHOOL DISTRICT SCHOOL HEALTH PLAN: DIABETES of Plan: Effective s: This
More informationStroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Special Situations. Askiel Bruno, MD, MS Protocol PI
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Special Situations Askiel Bruno, MD, MS Protocol PI Hypoglycemia Protocol General Concepts The hypoglycemia prevention protocol
More informationDiabetes Medical Management Plan
of Plan: Diabetes Medical Management Plan (Adapted for JHU/CTY Summer Programs) This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed with
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the camper s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant staff and copies
More informationType I Type II Insulin Resistance
Insulin An aqueous hormonal solution made in the pancreas. Affects metabolism by allowing glucose to leave the blood and enter the body cells, preventing hyperglycemia. It is measured in units, e.g. 100
More informationPumping Insulin is it for your patients?
Pumping Insulin is it for your patients? YOU CAN make managing diabetes easier. Fred Porcase D.O. Disclosures to Participants Conflicts Of Interest and Financial Relationships Disclosures: No professional
More informationREQUIREMENTS SPECIFICATION
REQUIREMENTS SPECIFICATION The control software for an automated insulin pump CSc 365 Critical Systems Engineering 2002 Revised version, 2001/2002. Page 1, 18/7/02 1. Introduction This specification defines
More informationPumps & Sensors made easy. OPADA ALZOHAILI MD FACE Endocrinology Assistant Professor Wayne State University
Pumps & Sensors made easy OPADA ALZOHAILI MD FACE Endocrinology Assistant Professor Wayne State University DeFronzo RA. Diabetes. 2009;58:773-795. Ominous Octet Relationship of b-cell Dysfunction and Development
More informationDIABETIC MANAGEMENT PLAN
DIABETIC MANAGEMENT PLAN Parent Consent and Physician Authorization POWAY UNIFIED SCHOOL DISTRICT HEALTH SERVICES 15250 Avenue of Science, San Diego, CA 92128 Dear Parent/Guardian and Physician of California
More informationCGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER
CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER Case 1: CGM use during pregnancy 29 yo G1P0000 at 10 5/7 weeks gestation presents to set
More informationChief of Endocrinology East Orange General Hospital
Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage
More informationVICTORIA INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan
VICTORIA INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. Student s Name: of Birth: of Diabetes
More informationHow to Transfer Your Settings
How to Transfer Your Settings for your Replacement MiniMed 530G System Let s get started! Step 1: Before you send your original pump back, copy your current settings onto the Insulin Pump Settings Form.
More informationDiabetes: Inpatient Glucose control
Diabetes: Inpatient Glucose control Leanne Current, PharmD, BCPS This activity is funded through the Medicaid section 1115(a) Demonstration Texas Healthcare Transformation and Quality Improvement Program
More informationUSING THE MINIMED 670G SYSTEM
USING THE MINIMED 670G SYSTEM Instructions for the Experienced MiniMed 630G System User USING THE MINIMED 670G SYSTEM: INSTRUCTIONS FOR THE EXPERIENCED USER Checklist for starting on your MiniMed 670G
More informationAviva Combo BLOOD GLUCOSE METER. Advanced Owner s Booklet for Self-Testing Only
Aviva Combo BLOOD GLUCOSE METER Advanced Owner s Booklet for Self-Testing Only Before You Start Testing About the meter and test strips Carefully read and follow the instructions in the Getting Started
More informationDiabetes Medical Management Plan
Date of Plan: Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed with relevant school staff and copies
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant school staff
More informationDiabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE
Diabetes and Technology Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Disclosure Speaker s Bureau: Janssan Pharmaceuticals Current Technology V-Go by Valeritas Continuous Sensors (personal
More information2016 Diabetes Management Plan
Early childhood education and care setting 2016 Diabetes Management Plan Insulin pump therapy [to be used in conjunction with Action Plan] Name of child: Date of birth: Name of centre: Age : This plan
More informationDear Parents/Guardians:
CEDAR MOUNTAIN PRIMARY SCHOOL P.O. Box 420/17 Sammis Road, Vernon, NJ 07462 Phone: 973-764-2890 Fax: 973-764-3294 Web: www.vtsd.com Dear Parents/Guardians: Rosemary Gebhardt, Principal rgebhardt@vtsd.com
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) Page 1 of 7, DMMP This plan should be completed by the student s personal diabetes health care team, including the parents/guardians. It should be reviewed with
More informationGLOOKO FOR ios MIDS USER GUIDE
GLOOKO FOR ios MIDS USER GUIDE October 2018 IFU-0001 13 Glooko MIDS is cleared for US only Rx only TABLE OF CONTENTS TABLE OF CONTENTS MOBILE INSULIN DOSING SYSTEM (MIDS)... 2 Intended Use... 2 Warnings...
More informationfor school staff Developed for Chicago Public Schools by: LaRabida Children s Hospital and Children s Memorial Hospital November 18, 2011
1 Diabetes Education for school staff Developed for Chicago Public Schools by: LaRabida Children s Hospital and Children s Memorial Hospital November 18, 2011 Chicago Public Schools Office of Special Education
More informationDiabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018
Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018 Pumps & Sensors & Meters, Oh My! A Tale of Two Meters Technology for glucometers
More information